Endoxifen, a New Treatment Option for Mania: A Double‐Blind, Active‐Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen

The protein kinase C (PKC) signaling system plays a role in mood disorders and PKC inhibitors such as endoxifen may be an innovative medicine for bipolar disorder (BP) patients. In this study we show for the first time the antimanic properties of endoxifen in patients with bipolar I disorder (BPD I)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, A, Sheikh, S, Shah, T, Reddy, MS, Prasad, BSV, Verma, KK, Chandrakant, BB, Paithankar, M, Kale, P, Solanki, RV, Patel, R, Barkate, H, Ahmad, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350997/
https://www.ncbi.nlm.nih.gov/pubmed/27346789
http://dx.doi.org/10.1111/cts.12407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350997/
https://www.ncbi.nlm.nih.gov/pubmed/27346789
http://dx.doi.org/10.1111/cts.12407

Ejemplares similares